- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
J
JAZZ
Jazz Pharmaceuticals Plc
172.19
2.60+1.53%After Hours: 175.00 +2.81 +1.63%19:13 02/20 EST
OPEN/PREV CLOSE169.34/169.59
TODAY RANGE168.56-172.46
VOL1.31M
MARKET CAP10.46B
52 WEEK RANGE95.49-182.99
AVG VOL (3M)991.30K
% TURNOVER2.16%
TURNOVER--
P/E (TTM)-28.3688
% RANGE2.30%
EPS(TTM)-6.0697
P/E(FORWARD)-27.0314
P/B2.642
BVPS65.18
DIVIDEND--
P/S2.566
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP10.14B
SHARES OUTSTANDING60.77M
NEXT EARNINGS02/23-02/27
FREE FLOAT58.88M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
PR Newswire·3d ago
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Simply Wall St·6d ago
Renee Gala Outlines Jazz Pharmaceuticals Vision And Pipeline Priorities For Investors
Simply Wall St·02/11 10:30
Is Jazz Pharmaceuticals (JAZZ) Pricing Reflect A 27.4% One Year Return And DCF Upside?
Reuters·02/10 21:16
Jazz Pharmaceuticals plc announces upcoming financial results webcast
Simply Wall St·02/08 14:05
Jazz Pharmaceuticals (JAZZ) Valuation After HERIZON GEA Trial Upside And Planned 2026 sBLA Filing
Simply Wall St·02/06 23:13
How HERIZON-GEA’s First-Line GEA Data And sBLA Plan At Jazz Pharmaceuticals (JAZZ) Has Changed Its Investment Story
Reuters·02/03 13:05
Rigel Pharmaceuticals Appoints Michael P. Miller to Board of Directors
Seeking Alpha·02/02 20:47
Harmony Biosciences Makes The Grade
Simply Wall St·01/31 18:20
Is Jazz Pharmaceuticals (JAZZ) Offering Opportunity After A 32% One Year Share Price Gain
TipRanks·01/30 13:35
ALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
Same Industry
Name/Symbol
Change%
Price